CSPC Innovation Pharmaceutical Co Ltd Class A - Asset Resilience Ratio
CSPC Innovation Pharmaceutical Co Ltd Class A (300765) has an Asset Resilience Ratio of 5.64% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2025)
This chart shows how CSPC Innovation Pharmaceutical Co Ltd Class A's Asset Resilience Ratio has changed over time. Check strategic asset allocation of CSPC Innovation Pharmaceutical Co Ltd Cl to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down CSPC Innovation Pharmaceutical Co Ltd Class A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of CSPC Innovation Pharmaceutical Co Ltd Cl.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥350.30 Million | 5.64% |
| Total Liquid Assets | CN¥350.30 Million | 5.64% |
Asset Resilience Insights
- Limited Liquidity: CSPC Innovation Pharmaceutical Co Ltd Class A maintains only 5.64% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
CSPC Innovation Pharmaceutical Co Ltd Class A Industry Peers by Asset Resilience Ratio
Compare CSPC Innovation Pharmaceutical Co Ltd Class A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Saputo Inc
TO:SAP |
Packaged Foods | 3.36% |
|
Orkla ASA
OL:ORK |
Packaged Foods | 4.19% |
|
Tingyi (Cayman Islands) Holding Corp
F:TYG |
Packaged Foods | 5.13% |
|
Maple Leaf Foods Inc.
TO:MFI |
Packaged Foods | 4.21% |
|
Grupo Herdez S.A.B. de C.V
MX:HERDEZ |
Packaged Foods | 0.28% |
|
Scandi Standard publ AB
ST:SCST |
Packaged Foods | 3.65% |
|
Kri-Kri Milk Industry S.A
AT:KRI |
Packaged Foods | 1.34% |
|
Namchow Food Group (Shanghai) Co. Ltd.
SHG:605339 |
Packaged Foods | 1.48% |
Annual Asset Resilience Ratio for CSPC Innovation Pharmaceutical Co Ltd Class A (2019–2025)
The table below shows the annual Asset Resilience Ratio data for CSPC Innovation Pharmaceutical Co Ltd Class A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 6.14% | CN¥385.39 Million ≈ $56.39 Million |
CN¥6.28 Billion ≈ $918.42 Million |
-1.67pp |
| 2024-12-31 | 7.81% | CN¥470.09 Million ≈ $68.79 Million |
CN¥6.02 Billion ≈ $881.22 Million |
-3.25pp |
| 2021-12-31 | 11.06% | CN¥413.59 Million ≈ $60.52 Million |
CN¥3.74 Billion ≈ $547.46 Million |
+0.17pp |
| 2020-12-31 | 10.89% | CN¥321.94 Million ≈ $47.11 Million |
CN¥2.96 Billion ≈ $432.64 Million |
-22.77pp |
| 2019-12-31 | 33.66% | CN¥960.09 Million ≈ $140.49 Million |
CN¥2.85 Billion ≈ $417.39 Million |
-- |
About CSPC Innovation Pharmaceutical Co Ltd Class A
CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally. The company offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dyphylline, theobromine, pentoxifylline, and doxofylline; and health food product… Read more